4-Benzyloxazolidine-2,5-dione,
583-47-1,
4-benzyl-1,3-oxazolidine-2,5-dione,
4-Benzyl-2,5-oxazolidinedione,
L-Phe-NCA,
2,5-Oxazolidinedione, 4-(phenylmethyl)-,
37498-95-6,
AK-94111,
NSC36252,
(S)-(-)-4-Benzyloxazolidine-2,5-dione,
EINECS 209-503-1,
AC1L29V7,
AC1Q6H72,
SCHEMBL6471382,
CTK5A8191,
DL-Phenylalanin-N-carboxyanhydrid,
6097AJ,
KM0190,
MFCD18375238,
NSC-36252,
AKOS022183104,
4-(phenylmethyl)oxazolidine-2,5-dione,
FCH1119467,
TRA0031221,
2,5-Oxazolidinedione,4-(phenylmethyl)-,
1892-35-9,
AS-31704,
SY007695,
SY062318,
SY225254,
AB0063995,
AX8268988,
DB-020461,
TC-224033,
FT-0746694,
4-(phenylmethyl)-1,3-oxazolidine-2,5-dione,
MFCD03411306 (95%),
MFCD03411307 (95%),
MFCD18375238 (95+%),
A808749,
(R)-4-Benzyloxazolidine-2,5-dione,
C10H9NO3,
(S)-4-Benzyloxazolidine-2,5-dione,
C10-H9-N-O3,
CID68501,
AR-1G1070,
14825-82-2,
60085-61-2,